Total raised
—
Last: Seed 2015-12
Stage
Seed
Founded
2013
Headcount
6
HQ
—
Sector
Health Tech & Life Sciences
About
VisiDome is developing an add-on accommodative intraocular lens (IOL) that restores cataract patients ability to focus clearly on objects at any distance, eliminating the need for glasses after cataract surgery. The companys IOL harnesses the strength of the ciliary muscle combined with efficient shape-changing optics, guaranteeing a large magnitude of accommodation for a wide and sufficient range of clear vision. The company was founded in the Misgav Incubator. The IOL underwent successful preclinical trials toward first-in-human use.
Funding history · 1 round · — total
2015-12
Seed
Undisclosed
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is VisiDome's primary product?
- VisiDome is developing an add-on accommodative intraocular lens (IOL) designed to restore clear vision at all distances for cataract patients, potentially eliminating the need for glasses after surgery.
- When was VisiDome founded?
- VisiDome was founded in October 2013.
- What is the current operational status of VisiDome?
- VisiDome is currently inactive, having ceased operations in February 2023.
- Where was VisiDome initially founded?
- VisiDome was founded in the Misgav Incubator, located in the Misgav Regional Council, Tchelet Street 17, Israel.
- Has VisiDome's IOL undergone any trials?
- Yes, VisiDome's IOL underwent successful preclinical trials in preparation for first-in-human use.
- When did VisiDome raise its last known funding round?
- VisiDome raised a Seed round in December 2015.
- Which investors participated in VisiDome's Seed round?
- The Seed round in December 2015 included investments from The Trendlines Group and Mor Research Applications. For a full financing history, please refer to startupim.
- How many employees did VisiDome have?
- VisiDome had 6 employees.
- Who are the founders of VisiDome?
- The founders of VisiDome are Nir Betser and Prof. Ehud Assia.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Tags
eye-diseaseslensesophthalmologymedical-devicessurgeryoptronicsmedical-technologies